Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$23.57 - $34.85 $487,239 - $720,419
-20,672 Reduced 32.09%
43,747 $1.5 Million
Q1 2024

May 14, 2024

BUY
$24.92 - $30.02 $1.61 Million - $1.93 Million
64,419 New
64,419 $1.62 Million
Q1 2022

May 13, 2022

SELL
$15.5 - $23.93 $813,347 - $1.26 Million
-52,474 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$13.05 - $19.35 $329,134 - $488,026
25,221 Added 92.54%
52,474 $837,000
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $380,179 - $549,965
27,253 New
27,253 $543,000
Q2 2021

Aug 16, 2021

SELL
$15.84 - $20.6 $230,788 - $300,142
-14,570 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$16.29 - $21.92 $237,345 - $319,374
14,570 New
14,570 $289,000
Q3 2020

Nov 16, 2020

SELL
$18.4 - $26.59 $323,840 - $467,984
-17,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.51 - $20.97 $202,576 - $369,072
17,600 New
17,600 $342,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.